Leading producer of gelatin and collagen peptides, Rousselot, started 2018 with a strong focus on innovation, in line with the company’s global strategy. In March, alongside the launch of two new revolutionary products – Peptan® IIm - hydrolyzed collagen type II matrix for joint health and StabiCapsTM gelatins preventing crosslinking in softgels, the company held the two-day event at its Expertise Center in Ghent and laid the foundation stone for the new Rousselot Pilot Hall at the site. With state-of-the-art R&D and Applications laboratories across the world dedicated to scientific research, new product development and co-innovation, Rousselot has committed to further strengthen this aspect of its service offering, and to keep working closely with customers to support their growth and formulation objectives.
2018 Innovation Days: a resounding success
The customer event, hosting about 100 people, was developed around the theme: Innovation Days 2018, new perspectives in the pharma & nutraceutical world. It provided customers with a unique perspective on the product launches and allowed them to appreciate gelatin and collagen’s unique potential for pioneering technologies in health care and medicine. Delegates were also offered the opportunity to visit the laboratories and discuss specific projects and opportunities with Rousselot and Peptan experts.
‘During these two days, Rousselot and Peptan have clearly demonstrated how to give a tangible dimension to innovation, not only by launching two new, innovative products, but also by looking at the future of our business under a new light’, comments Sandor Noordermeer, Vice-President Global Marketing & Sales.
‘The event represents the realization of our efforts to position ourselves as a trusted partner that not only provides high quality, safe ingredients, but that can also add value in every phase of the innovation process. We are very excited to see the results of our conversations and look forward to the next occasion’ adds Noordermeer.
Building the future of innovation
In parallel to the Innovation Days, Rousselot also announced the expansion of the Ghent site with a new Pilot facility. The new building, scheduled for completion in early 2019, will be fully dedicated to Rousselot’s and Peptan’s innovation pipeline. The teams will be responsible for the testing, on an industrial scale, of the progress and developments carried out at the Rousselot Expertise Center and the Regional Application Laboratories. The new laboratory will ensure the sustainability of the newly developed innovation concepts as well as accelerate their adoption in the pharma, nutrition and food industry.
Jos Vervoort, Executive Vice-President, Rousselot comments: The construction of this new Rousselot Pilot Hall and the Innovation Days are only the first steps of our improved commitment to bringing innovation closer to our customers, a top priority within our business strategy. Sharing our knowledge and fostering the discussion on key topics such as health care and medical science developments is one of the ways we help them stay ahead of the market and achieve their ambitions.
Rousselot and Peptan experts will be available to discuss the latest innovations and specific opportunities at Vitafoods 2018, stand H35.
News, X Pure News